• Skip to primary navigation
  • Skip to main content
  • Skip to footer
ElevateBio

ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • Search
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact
  • End-to-End Capabilities


    End-to-End Capabilities Overview

    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms


    Technology Platform Overview

    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches


    Therapeutic Design & Approaches Overview

    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
Home/End-to-End Capabilities

End-to-End Capabilities

We have the expertise, technologies, and state-of-the-art facilities at ElevateBio BaseCamp® to deliver genetic medicines from concept through commercialization, all under a single roof, right from the start.

// End-to-end
   Capabilities

Scaling New Heights, From BaseCamp to Summit

BaseCamp® is our genetic medicine current Good Manufacturing Practice (cGMP) manufacturing and process development business enabling biopharmaceutical partners with end-to-end capabilities.

The purpose-built viral vector and cell therapy centers of excellence provide the tools, expertise, and resources necessary to bring these advanced therapies from concept to commercialization.

We are leading the revolution in cell and gene therapy development, first through our flagship BaseCamp facility in Waltham, Massachusetts and beyond as we expand to new intersections of science, technology, and talent.

Download our BaseCamp Factsheet

Cell Therapies

We provide a full-spectrum solution for cell therapy manufacturing with tools and expertise in place to support across process development, analytical development, CMC regulatory, manufacturing and more.

Viral Vectors

We offer an unmatched array of viral vector services to support across all stages of development, including end-to-end process development and manufacturing for lentiviral and adeno-associated virus (AAV) vectors.

mRNA Therapeutics & Vaccines

We provide comprehensive GMP manufacturing solutions for mRNA vaccines and genetic medicines for all phases of development.

Learn more about

cGMP Manufacturing and Automation
Process Development
Analytical Services and Quality
Next-Generation Sequencing
Apheresis
Enabling Services
cGMP Manufacturing and Automation

cGMP Manufacturing and Automation

Our cGMP manufacturing facility is equipped for the full product lifecycle.

Learn More

Process Development

Process Development

In cell and gene therapies, the process is the product. We have deep expertise developing and scaling processes for cell therapies and viral vectors, including lentiviral vectors and AAV.

Learn More

Analytical Services and Quality

Analytical Services and Quality

Our robust analytical capabilities support development processes and ensure our products are well characterized, safe and meet regulatory guidelines.

Learn More

Next-Generation Sequencing

Next-Generation Sequencing

We offer a wide range of sequencing options to meet your cell and gene therapy needs.

Learn More

Apheresis

Apheresis

We can provide ‘needle to needle’ support for your products, including managing apheresis and incorporating it within your development and manufacturing process.

Learn More

Enabling Services

Enabling Services

Our team of experts can help you navigate the complex manufacturing and development lifecycle for genetic medicines from bench to bedside.

Learn More

From Concept to Commercialization, We’ll be Your Guide

LentiPeak

Our Customizable LentiPeak™ Platform

Our proprietary lentiviral vector (LVV) platform can be completely customized to meet your specific development needs. LentiPeak™, our suspension-based, scalable lentiviral vector production platform, enables efficient transition for cell and gene therapies from preclinical stage through clinical development and commercialization with accelerated timelines and reduced manufacturing costs.

Learn more

Our Technology Platforms

Our next-generation enabling technologies offer the potential to pursue a broad range of therapeutic designs and applications. With proprietary gene editing, cell therapy enabling technologies, and RNA, protein, and vector engineering technologies and the ability to combine them, we can power the entire cell and gene therapy industry.

Learn about our technology

Our Therapeutic Approaches

We are enabling the development of a range of ex vivo and in vivo cell and gene therapies, leveraging our in-house capabilities and expertise to design and develop an array of modalities.

Learn about our therapeutic designs

Partner with ElevateBio®

Wherever you are in your product lifecycle, we can strengthen and accelerate the development of your transformative therapies with our enabling technologies unmatched manufacturing capabilities.

Work with Us

// Work with us

Footer

ElevateBio

Investors & Media

LinkedIn Twitter

© 2025 ElevateBio. All Rights Reserved.

Privacy & Cookie Policy

  • End-to-End Capabilities
  • Technology Platforms
  • Therapeutic Design & Approaches
  • Partnering
  • About
  • Investors & Media
  • Careers
  • Contact
MENU
  • End-to-End Capabilities
    • End-to-End Capabilities Overview
    • cGMP Manufacturing and Automation
    • Process Development
    • Analytical Services and Quality
    • Next-Generation Sequencing
    • Apheresis
    • Enabling Services
  • Technology Platforms
    • Technology Platforms Overview
    • Gene Editing
    • Cell Therapy Enabling Technologies
    • RNA, Protein & Vector Engineering
  • Therapeutic Design & Approaches
    • Therapeutic Design & Approaches Overview
    • Ex Vivo Cell & Gene Therapies
    • In Vivo Gene Therapies
  • Partnering
    • Partnering Overview
    • Industry Partnerships
    • Academic Partnerships
  • About
    • About Overview
    • Our Story
    • Our Ecosystem
    • Our Team
    • Culture of Expedition
    • Careers
  • Investors & Media
    • Investors & Media Overview
    • Press Releases
    • Posters & Publications
    • Elevated Insights
  • Careers
  • Locations
  • Contact